Qsymia the more effective of the pair in clinical trials
(Newser) -
After 13 years without approving a new weight-loss drug, the FDA has now approved two within three weeks. After June's approval of Belviq , the FDA yesterday approved Qsymia, which used to be called Qnexa ; both drugs had previously been rejected. In studies, Qsymia resulted in the greater weight loss:...